Inovio, Amneal Slash Workforces as Both Companies Undergo RealignmentsAllbiopro2019-07-18T09:32:22+09:007월 18th, 2019|
Kite’s Belldegrun Launches Biotech-Focused Real Estate Company, Breakthrough PropertiesAllbiopro2019-07-18T09:31:50+09:007월 18th, 2019|
China Has Big Presence in Top 10 Biotech IPOs this YearAllbiopro2019-07-18T09:31:19+09:007월 18th, 2019|
Kite, A Gilead Company, Announces Plans For New 67,000-Square-Foot Cell Therapy Manufacturing Facility In CA; Dedicated To Viral VectorsAllbiopro2019-07-18T09:30:51+09:007월 18th, 2019|
Seattle Genetics investors breathe a sigh of relief as Adcetris posts 30% sales growthAllbiopro2019-07-18T09:30:17+09:007월 18th, 2019|
3 drugmakers dominated opioid supplies as 76B pills flooded the U.S.: reportAllbiopro2019-07-18T09:29:43+09:007월 18th, 2019|
Novartis’ Kisqali, trailing Lilly’s Verzenio, nabs limited NICE backing in breast cancerAllbiopro2019-07-18T09:29:13+09:007월 18th, 2019|
Publicis’ ‘Shark Tank’-style digital tech showdown crowns smart intranasal device as winnerAllbiopro2019-07-18T09:28:43+09:007월 18th, 2019|
FDA investigators discover key Strides Pharma quality records in shredding roomAllbiopro2019-07-18T09:28:09+09:007월 18th, 2019|
Gilead CEO O’Day continues top-level revamp with two more exec exitsAllbiopro2019-07-18T09:27:36+09:007월 18th, 2019|
Top Indian drugmakers expand in China as policy changes trigger opportunityAllbiopro2019-07-18T09:27:06+09:007월 18th, 2019|
Orum Therapeutics bags $30M to build out its platform to drug the ‘undruggable’Allbiopro2019-07-18T09:26:33+09:007월 18th, 2019|
Reversing the risk of sudden cardiac death with gene therapyAllbiopro2019-07-18T09:25:59+09:007월 18th, 2019|
FDA goes against AdComm votes 22% of the time, study findsAllbiopro2019-07-18T09:25:31+09:007월 18th, 2019|
Immusoft names former Amgen biologics chief as chief scientific officerAllbiopro2019-07-18T09:24:59+09:007월 18th, 2019|
Inovio axes staffers, cancer program to ‘sharpen focus,’ save cashAllbiopro2019-07-18T09:24:26+09:007월 18th, 2019|
Astellas picks up Frequency’s regenerative hearing loss med outside U.S. for $80MAllbiopro2019-07-18T09:23:56+09:007월 18th, 2019|
Multiple myeloma MAb helps drive Q2 as J&J looks to subcu formulationAllbiopro2019-07-18T09:23:23+09:007월 18th, 2019|
